Highlights
The global Approved COVID-19 Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Approved COVID-19 Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Approved COVID-19 Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô, Heat Biologics and Sanofi, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Approved COVID-19 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Approved COVID-19 Vaccines.
The Approved COVID-19 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Approved COVID-19 Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Approved COVID-19 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô
Heat Biologics
Sanofi
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Approved COVID-19 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Approved COVID-19 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Approved COVID-19 Vaccines Â鶹Դ´ Overview
1.1 Product Overview and Scope of Approved COVID-19 Vaccines
1.2 Approved COVID-19 Vaccines Segment by Type
1.2.1 Global Approved COVID-19 Vaccines Â鶹Դ´ Value Comparison by Type (2023-2029)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines Segment by Application
1.3.1 Global Approved COVID-19 Vaccines Â鶹Դ´ Value by Application: (2023-2029)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Â鶹Դ´ Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2018-2029
1.4.2 Global Approved COVID-19 Vaccines Sales 2018-2029
1.4.3 Global Approved COVID-19 Vaccines Â鶹Դ´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Approved COVID-19 Vaccines Â鶹Դ´ Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Â鶹Դ´ Share by Manufacturers (2018-2023)
2.2 Global Approved COVID-19 Vaccines Revenue Â鶹Դ´ Share by Manufacturers (2018-2023)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Approved COVID-19 Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Approved COVID-19 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Approved COVID-19 Vaccines, Product Type & Application
2.7 Approved COVID-19 Vaccines Â鶹Դ´ Competitive Situation and Trends
2.7.1 Approved COVID-19 Vaccines Â鶹Դ´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Â鶹Դ´ Share by Revenue
2.7.3 Global Approved COVID-19 Vaccines Â鶹Դ´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Â鶹Դ´ Scenario by Region
3.1 Global Approved COVID-19 Vaccines Â鶹Դ´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Sales by Region: 2018-2029
3.2.1 Global Approved COVID-19 Vaccines Sales by Region: 2018-2023
3.2.2 Global Approved COVID-19 Vaccines Sales by Region: 2024-2029
3.3 Global Approved COVID-19 Vaccines Global Approved COVID-19 Vaccines Revenue by Region: 2018-2029
3.3.1 Global Approved COVID-19 Vaccines Revenue by Region: 2018-2023
3.3.2 Global Approved COVID-19 Vaccines Revenue by Region: 2024-2029
3.4 North America Approved COVID-19 Vaccines Â鶹Դ´ Facts & Figures by Country
3.4.1 North America Approved COVID-19 Vaccines Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Approved COVID-19 Vaccines Sales by Country (2018-2029)
3.4.3 North America Approved COVID-19 Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Approved COVID-19 Vaccines Â鶹Դ´ Facts & Figures by Country
3.5.1 Europe Approved COVID-19 Vaccines Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Approved COVID-19 Vaccines Sales by Country (2018-2029)
3.5.3 Europe Approved COVID-19 Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Approved COVID-19 Vaccines Â鶹Դ´ Facts & Figures by Country
3.6.1 Asia Pacific Approved COVID-19 Vaccines Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Approved COVID-19 Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Approved COVID-19 Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Approved COVID-19 Vaccines Â鶹Դ´ Facts & Figures by Country
3.7.1 Latin America Approved COVID-19 Vaccines Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Approved COVID-19 Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Approved COVID-19 Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Approved COVID-19 Vaccines Â鶹Դ´ Facts & Figures by Country
3.8.1 Middle East and Africa Approved COVID-19 Vaccines Â鶹Դ´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Approved COVID-19 Vaccines Sales by Type (2018-2029)
4.1.1 Global Approved COVID-19 Vaccines Sales by Type (2018-2023)
4.1.2 Global Approved COVID-19 Vaccines Sales by Type (2024-2029)
4.1.3 Global Approved COVID-19 Vaccines Sales Â鶹Դ´ Share by Type (2018-2029)
4.2 Global Approved COVID-19 Vaccines Revenue by Type (2018-2029)
4.2.1 Global Approved COVID-19 Vaccines Revenue by Type (2018-2023)
4.2.2 Global Approved COVID-19 Vaccines Revenue by Type (2024-2029)
4.2.3 Global Approved COVID-19 Vaccines Revenue Â鶹Դ´ Share by Type (2018-2029)
4.3 Global Approved COVID-19 Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Approved COVID-19 Vaccines Sales by Application (2018-2029)
5.1.1 Global Approved COVID-19 Vaccines Sales by Application (2018-2023)
5.1.2 Global Approved COVID-19 Vaccines Sales by Application (2024-2029)
5.1.3 Global Approved COVID-19 Vaccines Sales Â鶹Դ´ Share by Application (2018-2029)
5.2 Global Approved COVID-19 Vaccines Revenue by Application (2018-2029)
5.2.1 Global Approved COVID-19 Vaccines Revenue by Application (2018-2023)
5.2.2 Global Approved COVID-19 Vaccines Revenue by Application (2024-2029)
5.2.3 Global Approved COVID-19 Vaccines Revenue Â鶹Դ´ Share by Application (2018-2029)
5.3 Global Approved COVID-19 Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô
6.6.1 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Corporation Information
6.6.2 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Description and Business Overview
6.6.3 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Approved COVID-19 Vaccines Product Portfolio
6.7.5 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Approved COVID-19 Vaccines Industry Chain Analysis
7.2 Approved COVID-19 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Approved COVID-19 Vaccines Production Mode & Process
7.4 Approved COVID-19 Vaccines Sales and Â鶹Դ´ing
7.4.1 Approved COVID-19 Vaccines Sales Channels
7.4.2 Approved COVID-19 Vaccines Distributors
7.5 Approved COVID-19 Vaccines Customers
8 Approved COVID-19 Vaccines Â鶹Դ´ Dynamics
8.1 Approved COVID-19 Vaccines Industry Trends
8.2 Approved COVID-19 Vaccines Â鶹Դ´ Drivers
8.3 Approved COVID-19 Vaccines Â鶹Դ´ Challenges
8.4 Approved COVID-19 Vaccines Â鶹Դ´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Â鶹Դ´ Size Estimation
10.1.3 Â鶹Դ´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô
Heat Biologics
Sanofi
Ìý
Ìý
*If Applicable.